We propose that our patients have a novel form of DPB deficiency, which we have designated type IV on the basis of their unique clinical, biochemical and genetic features, thereby expanding the phenotypic spectrum associated with alteration of DBP function. Here, DBP is linked to hyperinsulinemic hypoglycemia, familial, 4.